logo

Indian News

Share

corona-feb27.jpg The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.

pharma-050917_27feb20.jpg Today's Daily Dose brings you news about Menlo's Serlopitant trial results, Novavax's update on its efforts to develop a novel vaccine against coronavirus disease COVID-19, Oramed's oral insulin trial results and Vir Biotech's entry into coronavirus vaccine development space.

Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, has a couple of events lined up for this year.

nemaura-feb26.jpg Nemaura Medical Inc. (NMRD), which implemented a 1-for-10 reverse split on December 5, 2019, to regain compliance with NASDAQ, has gained more than 65 percent so far this year.

pharma-050517_25feb20.jpg Today's Daily Dose brings you news about IMV's ovarian cancer trial results, reports of Iovance considering a possible sale, Nemaura's head -to-head study with a major Glucose Monitoring System, and disappointing trial results of Vanda and Supernus.

donald-trump3-110718_25feb20.jpg President Donald Trump said Tuesday that markets will crash like never before if he loses the presidential election. Trump, who is on a two-day tour of India, made the remark during his interaction with CEOs of major Indian companies in New Delhi.

vaxart-feb25.jpg Shares of Vaxart Inc. (VXRT) have gained an impressive 265 percent so far this year on hopes of a vaccine for the novel coronavirus.

pharma-010919_24feb20.jpg Today's Daily Dose brings you news about NGM Biopharma's phase II NASH study results, Moderna's Coronavirus program, COCRYSTAL's focus on COVID-19 coronavirus and norovirus, Lipocine's update on the New Drug Application of TLANDO, growing woes of Mallinckrodt, and Takeda Pharma's date with FDA, among others.

trumpmodi-feb24.jpg U.S. President Donald Trump on Monday announced more than $3 billion of defense deals with India for helicopters and other military equipment on his arrival for a two-day tour of the South Asian country. "I'm pleased to announce that tomorrow our representatives will sign deals to sell over $3 billion, in the absolute finest state of the art military helicopters and other equipment to the Indian

soligenix-feb24.jpg Soligenix Inc. (SNGX), a late-stage biopharmaceutical company developing products to treat rare diseases, has multiple potential value drivers, making the stock worth watching.

Follow RTT
>